BCTXZ — BRIACELL THERAPEUTICS CORP
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 5 SEC-registered investment managers reported holding BCTXZ (BRIACELL THERAPEUTICS CORP) in their latest 13F filings, with a combined reported value of $61.68K across 631.70K shares. That is -41.9% by share count (-312.67K shares) versus the previous quarter, while reported value moved -59.1%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 2 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of BRIACELL THERAPEUTICS CORP (BCTXZ) include Empery Asset Management, LP, HRT FINANCIAL LP, HEIGHTS CAPITAL MANAGEMENT, INC, ranked by reported 13F value among the 7 institutional holders on this page.
BCTXZ is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 2 | 168.21K | $32.76K | +142.0% |
| Q2 2026 | 5 | 631.70K | $61.68K | -41.9% |
| Q1 2026 | 4 | 1.42M | $198.54K | -4.0% |
| Q4 2025 | 4 | 1.48M | $433.91K | -11.8% |
| Q3 2025 | 3 | 919.25K | $311.22K | -20.2% |
| Q2 2025 | 3 | 1.15M | $1.21M | — |
Over the 6 quarters shown, institutional share counts decreased 85% in aggregate (Q2 2025 → Q3 2026); the largest single-quarter swing was Q2 2026 (-41.9%).
Top Institutional Holders (Q3 2026) — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 164.38K | $32.00K | 0.00% | Add | |
| 3.83K | $758 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 313.38K | $31.34K | 0.01% | Reduce | |
| 120.80K | $11.46K | 0.08% | Reduce | |
| 114.52K | $11.45K | 0.00% | New | |
| 67.94K | $6.00K | 0.00% | New | |
| 15.06K | $1.43K | 0.00% | New |
Q1 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 666.60K | $93.32K | 0.11% | Hold | |
| 540.10K | $75.61K | 0.02% | Reduce | |
| 206.75K | $28.95K | 0.34% | Reduce | |
| 4.70K | $658 | 0.00% | Add |
Q4 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 666.60K | $193.31K | 0.17% | New | |
| 544.70K | $163.41K | 0.06% | Hold | |
| 265.96K | $77.18K | 0.56% | Reduce | |
| 5 | $1 | 0.00% | Reduce |
Q3 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 544.70K | $185.74K | 0.06% | Reduce | |
| 374.49K | $125.45K | 0.40% | Reduce | |
| 66 | $22 | 0.00% | Reduce |
Q2 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 598.74K | $634.67K | 3.56% | New | |
| 552.08K | $574.16K | 0.18% | New | |
| 1.19K | $1.26K | 0.00% | New |
New Positions (Q2 2026)
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 114.52K sh · $11.45K
- HRT FINANCIAL LP 67.94K sh · $6.00K
- TWO SIGMA SECURITIES, LLC 15.06K sh · $1.43K
Fully Exited (vs previous quarter)
- Empery Asset Management, LP sold 666.60K sh · $93.32K
- UBS Group AG sold 4.70K sh · $658
Fund Position History — shares by quarter (top 7 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 164.38K | 67.94K | — | — | — | — |
| UBS Group AG | 3.83K | — | 4.70K | 5 | 66 | 1.19K |
| SABBY MANAGEMENT, LLC | — | 120.80K | 206.75K | 265.96K | 374.49K | 598.74K |
| HEIGHTS CAPITAL MANAGEMENT, INC | — | 313.38K | 540.10K | 544.70K | 544.70K | 552.08K |
| Empery Asset Management, LP | — | — | 666.60K | 666.60K | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | — | 114.52K | — | — | — | — |
| TWO SIGMA SECURITIES, LLC | — | 15.06K | — | — | — | — |
FAQ
Which funds hold BCTXZ?
As of 2026-Q2, 5 institutional funds reported holding BCTXZ (BRIACELL THERAPEUTICS CORP) in SEC 13F filings, with a combined reported value of $61.68K.
How many shares of BCTXZ do institutions own?
13F filers reported 631.70K shares of BCTXZ, worth $61.68K in aggregate at the end of 2026-Q2.
Is institutional ownership of BCTXZ rising or falling?
Share counts moved -41.9% versus the prior quarter — distribution.
Who are the top institutional holders of BCTXZ?
The largest 13F holders are Empery Asset Management, LP, HRT FINANCIAL LP, HEIGHTS CAPITAL MANAGEMENT, INC, SABBY MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP; the top 25 are ranked at the top of this page.
Who are the major shareholders of BRIACELL THERAPEUTICS CORP?
The major shareholders of BRIACELL THERAPEUTICS CORP (BCTXZ) by reported 13F value are Empery Asset Management, LP, HRT FINANCIAL LP, HEIGHTS CAPITAL MANAGEMENT, INC, SABBY MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, among 7 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.